Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors.

Corona P, Gibellini F, Cavalli A, Saxena P, Carta A, Loriga M, Luciani R, Paglietti G, Guerrieri D, Nerini E, Gupta S, Hannaert V, Michels PA, Ferrari S, Costi PM.

J Med Chem. 2012 Oct 11;55(19):8318-29. doi: 10.1021/jm300563f. Epub 2012 Sep 19.

PMID:
22946585
2.

New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals.

Zecca L, Bellei C, Costi P, Albertini A, Monzani E, Casella L, Gallorini M, Bergamaschi L, Moscatelli A, Turro NJ, Eisner M, Crippa PR, Ito S, Wakamatsu K, Bush WD, Ward WC, Simon JD, Zucca FA.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17567-72. doi: 10.1073/pnas.0808768105. Epub 2008 Nov 6.

3.

An environmentally sustainable decision model for urban solid waste management.

Costi P, Minciardi R, Robba M, Rovatti M, Sacile R.

Waste Manag. 2004;24(3):277-95.

PMID:
15016417
4.
5.

The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour.

Zecca L, Zucca FA, Costi P, Tampellini D, Gatti A, Gerlach M, Riederer P, Fariello RG, Ito S, Gallorini M, Sulzer D.

J Neural Transm Suppl. 2003;(65):145-55. Review.

PMID:
12946053
6.

Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.

Double KL, Zecca L, Costi P, Mauer M, Griesinger C, Ito S, Ben-Shachar D, Bringmann G, Fariello RG, Riederer P, Gerlach M.

J Neurochem. 2000 Dec;75(6):2583-9.

7.

Interaction of human substantia nigra neuromelanin with lipids and peptides.

Zecca L, Costi P, Mecacci C, Ito S, Terreni M, Sonnino S.

J Neurochem. 2000 Apr;74(4):1758-65.

8.

Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition.

Costi PM, Rinaldi M, Tondi D, Pecorari P, Barlocco D, Ghelli S, Stroud RM, Santi DV, Stout TJ, Musiu C, Marangiu EM, Pani A, Congiu D, Loi GA, La Colla P.

J Med Chem. 1999 Jun 17;42(12):2112-24.

PMID:
10377217
9.

Effects of procainamide on the excitable gap composition in common human atrial flutter.

Jalil E, Le Franc P, Lebeau R, Molin F, Costi P, Kús T.

Pacing Clin Electrophysiol. 1998 Mar;21(3):528-35.

PMID:
9558683
10.

Underdetection of ventricular tachycardia using a 40 ms stability criterion: effect of antiarrhythmic therapy.

Le Franc P, Kuś T, Vinet A, Rocque P, Molin F, Costi P.

Pacing Clin Electrophysiol. 1997 Dec;20(12 Pt 1):2882-92.

PMID:
9455747
11.

Asparagine 229 mutants of thymidylate synthase catalyze the methylation of 3-methyl-2'-deoxyuridine 5'-monophosphate.

Costi PM, Liu L, Finer-Moore JS, Stroud RM, Santi DV.

Biochemistry. 1996 Apr 2;35(13):3944-9.

PMID:
8672425
12.

Comparison of the diagnostic yield of Holter versus transtelephonic monitoring.

Kus T, Nadeau R, Costi P, Molin F, Primeau R.

Can J Cardiol. 1995 Nov;11(10):891-4.

PMID:
7489527
13.

Behavioral and biochemical changes after bilateral electrolytic lesions of the red nucleus of rat.

Kolasa K, Consolo S, Costi P, Kleinrok Z, Zecca L.

Pharmacol Biochem Behav. 1995 May;51(1):29-35.

PMID:
7617729
14.

Heterodimeric thymidylate synthases with C-terminal deletion on one subunit.

Carreras CW, Costi PM, Santi DV.

J Biol Chem. 1994 Apr 29;269(17):12444-6.

15.
17.

Supplemental Content

Support Center